FMS (Fresenius Medical Care AG) Interest Expense : $-440 Mil (TTM As of Dec. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Fresenius Medical Care AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fresenius Medical Care AG's interest expense for the three months ended in Dec. 2024 was $ -106 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-440 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fresenius Medical Care AG's Operating Income for the three months ended in Dec. 2024 was $ 458 Mil. Fresenius Medical Care AG's Interest Expense for the three months ended in Dec. 2024 was $ -106 Mil. Fresenius Medical Care AG's Interest Coverage for the quarter that ended in Dec. 2024 was 4.33. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fresenius Medical Care AG Interest Expense Historical Data

The historical data trend for Fresenius Medical Care AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Interest Expense Chart

Fresenius Medical Care AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-498.76

-399.55

-381.50

-463.08

-426.22

Fresenius Medical Care AG Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-121.75	-113.04	-110.87	-109.88	-105.81

Fresenius Medical Care AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-440 Mil.

Fresenius Medical Care AG (NYSE:FMS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fresenius Medical Care AG's Interest Expense for the three months ended in Dec. 2024 was $-106 Mil. Its Operating Income for the three months ended in Dec. 2024 was $458 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was $10,221 Mil.

Fresenius Medical Care AG's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	457.99	/	-105.805
	=	4.33

The higher the ratio, the stronger the company's financial strength is.

Fresenius Medical Care AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

FMCQF:USA 1FME:Italy FMEd:UK 0H9X:UK FME:Germany FMEA:Germany FME:Germany FME:Germany FMEA:Germany FME:Germany FME:Austria

Address

Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.

Executives

Helen Pring Giza

Board of Directors